home / stock / gene / gene news

GENE News and Press, Genetic Technologies Ltd From 01/24/23

Stock Information
Company Name: Genetic Technologies Ltd
Stock Symbol: GENE
Market: NASDAQ
Website: gtglabs.com
Menu
GENE GENE Quote GENE Short GENE News GENE Articles GENE Message Board
Get GENE Alerts

News, Short Squeeze, Breakout and More Instantly...
GENE - Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium

MELBOURNE, Australia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce a poster presentatio...
GENE - Genetic Technologies Provides Business Update

MELBOURNE, Australia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,”Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to provide the following business...

GENE - GeneType published in PLOS ONE - development of polygenic risk scores for cardiovascular diseases and type 2 diabetes

MELBOURNE, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is delighted to announce the publication ...

GENE - Genetec's Q2FY2023 Performance Remains on Track

Genetec's Q2FY2023 Performance Remains on Track BANGI, Malaysia, Nov 29, 2022 - (ACN Newswire) - Technology leader in providing fully customised, intelligent manufacturing automation solutions, Genetec Technology Berhad announced their quarterly performance to date for their s...
GENE - Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease

MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies (ASX:GTG, NASDAQ:GENE) , a global leader in guideline driven Genomics based tests in health, wellness and serious disease will be hosting an interview between Dr Erika Spaeth (PhD Director of Clinical & Sci...

GENE - Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention

MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health, wellness and serious disease is delighted to announce the publicat...

GENE - Genetic Technologies Limited (GENE) Q1 2023 Earnings Call Transcript

Genetic Technologies Limited (GENE) Q1 2023 Earnings Conference Call November 3, 2022 08:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Presentation Adrian Mulcahy [Starts Abruptly] Geneti...
GENE - Genetic Technologies reports 375% rise in revenue in Q1

Genetic Technologies ( NASDAQ: GENE ) reported a 375% Y/Y rise in revenue from customers, helped by three of its brands geneType, EasyDNA, and AffinityDNA. Revenue from customers was A$1.93M for the quarter. The company had cash receipts of A$2.06M with a cash balance ...

GENE - Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

MELBOURNE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health, wellness and serious disease has released its results for the quar...

GENE - Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

ORLANDO, FL / ACCESSWIRE / October 13, 2022 / RedChip Companies will air a new interview with Genetic Technologies Limited (ASX:GTG)(NASDAQ:GENE) ("Company", "GTG"), a global leader in genomics-based tests in health, wellness, and serious disease, on The RedChip Money Report® on Bloombe...
Previous 10 Next 10